Literature DB >> 6752170

Natural and biosynthetic insulin stimulates the growth of human erythroid progenitors in vitro.

N Bersch, J E Groopman, D W Golde.   

Abstract

High concentrations of insulin are known to augment the growth of various cell types in vitro. We examined the effect of a purified porcine insulin and biosynthetic human insulin produced in E. coli on the growth of human erythroid progenitors in vitro. Both insulins stimulated peripheral blood erythroid colony formation within the physiological range. An approximately 2-fold augmentation in colony formation was seen at insulin concentrations of 8 ng/ml, and as little as 0.1 ng/ml (0.17 nM) caused detectable stimulation of colony formation. The effect of subnanomolar concentrations of insulin or erythropoiesis in vitro suggests that insulin could modulate erythropoiesis in vitro. Human responsiveness to insulin's growth-promoting activity can be directly assayed in vitro using peripheral blood.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6752170     DOI: 10.1210/jcem-55-6-1209

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Interactions of insulin, insulinlike growth factor II, and platelet-derived growth factor in erythropoietic culture.

Authors:  N Dainiak; S Kreczko
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

2.  Hematological parameters and metabolic syndrome: findings from an occupational cohort in Ethiopia.

Authors:  Kelsey Nebeck; Bizu Gelaye; Seblewengel Lemma; Yemane Berhane; Tamrat Bekele; Atsede Khali; Yoseph Haddis; Michelle A Williams
Journal:  Diabetes Metab Syndr       Date:  2012-06-15

3.  Ameliorative effects of Cnidoscolus aconitifolius on alloxan toxicity in Wistar rats.

Authors:  O I Azeez; A A Oyagbemi; M O Oyeyemi; A A Odetola
Journal:  Afr Health Sci       Date:  2010-09       Impact factor: 0.927

4.  Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.

Authors:  Ren-Nan Feng; Shan-Shan Du; Cheng Wang; Yan-Chuan Li; Li-Yan Liu; Fu-Chuan Guo; Chang-Hao Sun
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

5.  Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development.

Authors:  K Sawada; S B Krantz; E N Dessypris; S T Koury; S T Sawyer
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

6.  Hyperglycaemic Environment: Contribution to the Anaemia Associated with Diabetes Mellitus in Rats Experimentally Induced with Alloxan.

Authors:  Oseni Bashiru Shola; Fakoya Olatunde Olugbenga
Journal:  Anemia       Date:  2015-11-30

7.  Association of erythrocyte parameters with metabolic syndrome in the Pearl River Delta region of China: a cross sectional study.

Authors:  Ling Ling Huang; Dong-Mei Dou; Nan Liu; Xiao Xiao Wang; Li-Ying Fu; Xiao Wu; Peixi Wang
Journal:  BMJ Open       Date:  2018-01-10       Impact factor: 2.692

8.  Lymphocyte To High-Density Lipoprotein Ratio As A New Indicator Of Inflammation And Metabolic Syndrome.

Authors:  Haishan Chen; Xiaofei Shao; Chongxiang Xiong; Jing Ning; Peichun Gao; Hua Xiao; Yunying Chen; Ziliang Zou; Guobao Hong; Xiaolin Li; Mengjiao Shao; Jieli Sheng; Xingyan Yang; Xu You; Hequn Zou
Journal:  Diabetes Metab Syndr Obes       Date:  2019-10-14       Impact factor: 3.168

9.  The association between hematological parameters and insulin resistance is modified by body mass index - results from the North-East Italy MoMa population study.

Authors:  Rocco Barazzoni; Gianluca Gortan Cappellari; Annamaria Semolic; Enrico Chendi; Mario Ius; Roberta Situlin; Michela Zanetti; Pierandrea Vinci; Gianfranco Guarnieri
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

10.  Association between erythrocyte parameters and metabolic syndrome in urban Han Chinese: a longitudinal cohort study.

Authors:  Shuo Wu; Haiyan Lin; Chengqi Zhang; Qian Zhang; Dongzhi Zhang; Yongyuan Zhang; Wenjia Meng; Zhenxin Zhu; Fang Tang; Fuzhong Xue; Yanxun Liu
Journal:  BMC Public Health       Date:  2013-10-21       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.